Carlsmed Inc. (I82)
Munich
13.30
+0.10 (+0.76%)
Closed
Sep 21, 2026
Day's Range
13.3013.30
52 wk Range
7.7514.30
Financial Statements - I82 - Carlsmed Inc.
Revenue
50.51M▲ 85.9%
Net Income
-29.63M▼ 22.2%Net Margin -58.7%
EBITDA
-27.59M▼ 21.8%
Free Cash Flow
-30.33M▼ 18.3%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Sales | 50.51M | 27.16M |
| Cost of Goods | 12.47M | 7.11M |
| Gross Profit | 38.04M | 20.04M |
 Operating Expense | - | - |
| Operating Income | -30.57M | -24.12M |
| Non-Operating Interest | - | - |
| Other Income Expense | -328K | -144K |
| Pre Tax Income | -29.63M | -24.25M |
| Income Tax | - | - |
| Net Income | -29.63M | -24.25M |
| EPS Basic | -2.12 | -1.5 |
| EPS Diluted | -2.12 | -1.5 |
| Basic Shares Outstanding | 14.22M | 16.56M |
| Diluted Shares Outstanding | 14.22M | 16.56M |
| Ebit | -28.20M | -22.93M |
| Ebitda | -27.59M | -22.64M |
| Net Income Continuous Operations | -29.63M | -24.25M |
| Minority Interests | - | - |
| Preferred Stock Dividends | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
